Literature DB >> 2739585

Comparative effects of roxithromycin and erythromycin on cellular immune functions in vitro. 1. Uptake of 3H-macrolides by human macrophages.

A M Cuffini1, V Tullio, F Cimino, N A Carlone.   

Abstract

The degree of penetration of roxithromycin in human macrophages was evaluated and compared with that of erythromycin. The results indicated that both macrolides at concentrations of 2, 10 and 20 micrograms/ml were concentrated by macrophages, even if roxithromycin was consistently and significantly more accumulated than erythromycin. Comparison of the degree of penetration of the two drugs into dead, resident and stimulated phagocytes indicated that the process of transfer through the macrophage wall was of an active nature, related to the metabolic state of the cells. Analysis of the binding of the two macrolides to intracellular proteins showed that more binding sites were available for erythromycin than for roxithromycin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2739585

Source DB:  PubMed          Journal:  Microbios        ISSN: 0026-2633


  4 in total

1.  Efficacy of periprosthetic erythromycin delivery for wear debris-induced inflammation and osteolysis.

Authors:  Weiping Ren; Renwen Zhang; Monica Hawkins; Tong Shi; David C Markel
Journal:  Inflamm Res       Date:  2010-07-06       Impact factor: 4.575

Review 2.  Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use.

Authors:  A Markham; D Faulds
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

3.  Mitigative effect of erythromycin on PMMA challenged preosteoblastic MC3T3-E1 cells.

Authors:  Yi Shen; Weili Wang; Xiaomiao Li; David C Markel; Weiping Ren
Journal:  ScientificWorldJournal       Date:  2014-06-03

4.  Entry of sanfetrinem into human polymorphonuclear granulocytes and its cell-associated activity against intracellular, penicillin-resistant Streptococcus pneumoniae.

Authors:  A M Cuffini; V Tullio; A Bonino; A Allocco; A I Palarchio; N A Carlone
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.